Skip to main content

Arovella Therapeutics Ltd. Health Care

$0.050 (0%)

High

$0.05

Low

$0.05

Trades

132

Turnover

$407,237

Volume

8,117,500
30 June 2023 at 3:59pm
Register to track ALA and receive email alerts.
ALA Announcements on Price Chart

Latest Announcements

Headline Date
Update - Proposed issue of securities - ALA 29 June 2023 at 9:40am
Share Purchase Plan (SPP) Closing Date Extended 29 June 2023 at 9:35am
ALA advances iNKT technology option with UNC - supplement 27 June 2023 at 11:45am
Notification regarding unquoted securities - ALA 26 June 2023 at 4:50pm
ALA advances iNKT technology option with UNC 26 June 2023 at 9:50am
Investor Webinar Presentation 22 June 2023 at 10:35am
Becoming a substantial holder RM 21 June 2023 at 9:05am
Investor Webinar 19 June 2023 at 10:30am
Share Purchase Plan (SPP) Offer Booklet 15 June 2023 at 8:50am
Notice Under Section 708A 14 June 2023 at 10:50am
Application for quotation of securities - ALA 14 June 2023 at 10:45am
Investor Presentation 7 June 2023 at 10:45am
Proposed issue of securities - ALA 7 June 2023 at 10:45am
Proposed issue of securities - ALA 7 June 2023 at 10:45am
Proposed issue of securities - ALA 7 June 2023 at 10:45am
AROVELLA COMPLETES $4M PLACEMENT & LAUNCHES $1M SPP 7 June 2023 at 10:45am
Trading Halt 5 June 2023 at 9:25am
ALA presents at the 5th annual Allogenic Cell Therapy Summit 25 May 2023 at 8:45am
Change in substantial holding 22 May 2023 at 12:05pm
Change of Director's Interest Notice x3 5 May 2023 at 4:45pm
Notice Under Section 708A 5 May 2023 at 4:40pm
Application for quotation of securities - ALA 5 May 2023 at 4:40pm
Arovella's OroMist R&D facility closure completed 1 May 2023 at 10:10am
Response to ASX Query 26 April 2023 at 5:25pm
Constitution 26 April 2023 at 11:15am
Quarterly Appendix 4C and Activities Report 24 April 2023 at 10:20am
Notice Under Section 708A 21 April 2023 at 4:45pm
Application for quotation of securities - ALA 21 April 2023 at 4:45pm
Results of General Meeting 21 April 2023 at 12:20pm
Chairman's address and CEO's presentation to EGM 21 April 2023 at 9:50am
Response to ASX Aware Query 20 April 2023 at 10:20am
Notification regarding unquoted securities - ALA 19 April 2023 at 5:15pm
Arovella AACR Poster Webinar Presentation 19 April 2023 at 10:00am
ALA-101 confers survival benefit in leukemia model 17 April 2023 at 9:10am
Response to ASX Price Query 14 April 2023 at 3:25pm
Change in substantial holding 11 April 2023 at 4:20pm
Explanatory Webinar Presentation 4 April 2023 at 9:45am
Arovella iNKT Cell Platform Explanatory Webinar 28 March 2023 at 1:10pm
Notice of Extraordinary General Meeting/Proxy Form 23 March 2023 at 9:10am
Arovella to present at NWR virtual healthcare conference 16 March 2023 at 8:40am
Notice Under Section 708A 14 March 2023 at 5:50pm
Application for quotation of securities - ALA 14 March 2023 at 5:40pm
Proposed issue of securities - ALA 13 March 2023 at 9:45am
Initial Director's Interest Notice 13 March 2023 at 9:20am
Arovella appoints Dr Thomas Duthy as Non-Executive Chair 13 March 2023 at 8:45am
Proposed issue of securities - ALA 10 March 2023 at 5:30pm
Notification regarding unquoted securities - ALA 8 March 2023 at 10:20am
Notification of cessation of securities - ALA 3 March 2023 at 5:50pm
Arovella presents at Spark Plus Biotech Day in Singapore 24 February 2023 at 8:35am
Appendix 4D and Half Year Report 23 February 2023 at 10:05am
Register to track ALA and receive email alerts.